KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
600645 Vcanbio Cell & Gene Engineering Corp.,Ltd.
- 19.99
- -0.50-2.44%
Market Closed Dec 13 15:00 CST
9.35BMarket Cap86.91P/E (TTM)
20.41High19.81Low87.54KlotVolume20.41Open20.49Pre Close175.16MTurnover1.87%Turnover Ratio88.06P/E (Static)467.95MShares24.0852wk High2.59P/B9.35BFloat Cap12.8852wk Low22.54Limit Up467.77MShs Float79.58Historical High18.44Limit Down2.93%Amplitude1.23Historical Low--Dividend TTM20.01Avg Price47.42KlotAsk--Div YieldTTM100Lot Size35.93KlotBid
Vcanbio Cell & Gene Engineering Corp.,Ltd. News
Zhongyuan Xiehe: Legal Opinion of Beijing Guofeng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd.
Zhongyuan Kyowa: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Legal Opinion of Beijing Guofeng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
An indicative announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. 2024 Second Extraordinary General Meeting of Shareholders Meeting Data
Revised Constitution of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd.
Announcement of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on changing the scope of business and amending the company\'s articles of association
Notice of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the subsidiary signing of a supplementary agreement to the “Entrusted R&D Service Contract”
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on obtaining a notice of acceptance of the wholly-owned subsidiary\'s drug clinical trial application
Zhongyuan Xiehe: Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd.
Zhongyuan Xiehe: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
An indicative announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on holding the 2024 First Extraordinary General Meeting of Shareholders
Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. 2024 First Extraordinary General Meeting of Shareholders Meeting Data
Notice of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on convening the first extraordinary shareholders\' meeting in 2024
Announcement of Zhongyuan Union Cell Genetic Engineering Co., Ltd. on the appointment of an accounting firm
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the wholly-owned subsidiary obtaining a notice of approval for drug clinical trials
